Welcome to LookChem.com Sign In|Join Free

CAS

  • or

53638-54-3

Post Buying Request

53638-54-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53638-54-3 Usage

General Description

8-NITROQUINAZOLIN-4-OL is a chemical compound with the molecular formula C8H5N3O3. It belongs to the class of nitroaromatic compounds and is primarily used in the synthesis of pharmaceuticals and other organic compounds. The presence of the nitro group makes this compound an important intermediate in the production of various functional materials such as dyes, resins, and pigments. 8-NITROQUINAZOLIN-4-OL may also be used as a reagent in chemical reactions in the laboratory and has potential applications in the field of medicinal chemistry. Its chemical structure and properties make it a versatile building block in organic synthesis and it is an important compound for research and development in the pharmaceutical and chemical industries.

Check Digit Verification of cas no

The CAS Registry Mumber 53638-54-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,6,3 and 8 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 53638-54:
(7*5)+(6*3)+(5*6)+(4*3)+(3*8)+(2*5)+(1*4)=133
133 % 10 = 3
So 53638-54-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H5N3O3/c12-8-5-2-1-3-6(11(13)14)7(5)9-4-10-8/h1-4H,(H,9,10,12)

53638-54-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 8-nitro-1H-quinazolin-4-one

1.2 Other means of identification

Product number -
Other names 8-Nitro-4-oxo-3,4-dihydro-chinazolin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53638-54-3 SDS

53638-54-3Synthetic route

3-nitroanthranilic acid
606-18-8

3-nitroanthranilic acid

8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

Conditions
ConditionsYield
at 140℃;79%
at 210℃;
With trichlorophosphate at 100℃;
2-amino-3-nitro-benzamide
313279-12-8

2-amino-3-nitro-benzamide

N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

A

8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

B

3-methyl-8-nitroquinazolin-4-one
221448-39-1

3-methyl-8-nitroquinazolin-4-one

C

cis-N'-(2-amino-3-nitrobenzoyl)-N,N-dimethylformamidine

cis-N'-(2-amino-3-nitrobenzoyl)-N,N-dimethylformamidine

D

trans-N'-(2-amino-3-nitrobenzoyl)-N,N-dimethylformamidine

trans-N'-(2-amino-3-nitrobenzoyl)-N,N-dimethylformamidine

Conditions
ConditionsYield
In tetrahydrofuran for 16h;A 19%
B 21%
C n/a
D n/a
3-nitroanthranilic acid
606-18-8

3-nitroanthranilic acid

8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

Conditions
ConditionsYield
With formamide In 2-methoxy-ethanol at 200℃; for 17h;14%
3-nitroanthranilic acid
606-18-8

3-nitroanthranilic acid

formamidine hydrochloride
6313-33-3

formamidine hydrochloride

8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

Conditions
ConditionsYield
at 200℃;
N,N-dimethylformamide diisopropyl acetal
18503-89-4

N,N-dimethylformamide diisopropyl acetal

2-amino-3-nitro-benzamide
313279-12-8

2-amino-3-nitro-benzamide

A

8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

B

3-methyl-8-nitroquinazolin-4-one
221448-39-1

3-methyl-8-nitroquinazolin-4-one

C

4-isopropoxy-8-nitroquinazoline

4-isopropoxy-8-nitroquinazoline

D

8-nitro-3-(prop-2-yl)quinazolin-4-one
1332493-34-1

8-nitro-3-(prop-2-yl)quinazolin-4-one

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 150℃;
3-nitroanthranilic acid
606-18-8

3-nitroanthranilic acid

A

8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

B

3-methyl-8-nitroquinazolin-4-one
221448-39-1

3-methyl-8-nitroquinazolin-4-one

C

cis-N'-(2-amino-3-nitrobenzoyl)-N,N-dimethylformamidine

cis-N'-(2-amino-3-nitrobenzoyl)-N,N-dimethylformamidine

D

trans-N'-(2-amino-3-nitrobenzoyl)-N,N-dimethylformamidine

trans-N'-(2-amino-3-nitrobenzoyl)-N,N-dimethylformamidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: thionyl chloride / tetrahydrofuran; N,N-dimethyl-formamide / 16 h
2: tetrahydrofuran / 16 h
View Scheme
3-nitroanthranilic acid
606-18-8

3-nitroanthranilic acid

A

8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

B

3-methyl-8-nitroquinazolin-4-one
221448-39-1

3-methyl-8-nitroquinazolin-4-one

C

4-isopropoxy-8-nitroquinazoline

4-isopropoxy-8-nitroquinazoline

D

8-nitro-3-(prop-2-yl)quinazolin-4-one
1332493-34-1

8-nitro-3-(prop-2-yl)quinazolin-4-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: thionyl chloride / tetrahydrofuran; N,N-dimethyl-formamide / 16 h
2: N,N-dimethyl-formamide / 150 °C
View Scheme
3-nitroanthranilic acid
606-18-8

3-nitroanthranilic acid

ammonium acetate
631-61-8

ammonium acetate

8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

Conditions
ConditionsYield
at 150℃; for 2h; Sealed tube;1.8 g
3-nitroanthranilic acid
606-18-8

3-nitroanthranilic acid

8-nitroquinazoline-4(3H)-one

8-nitroquinazoline-4(3H)-one

Conditions
ConditionsYield
at 140℃;79%
at 210℃;
With trichlorophosphate at 100℃;
8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

8-aminoquinazolin-4(3H)-one
130148-49-1

8-aminoquinazolin-4(3H)-one

Conditions
ConditionsYield
With stannous chloride dihydrate In ethyl acetate for 8h; Reflux;72%
With methanol; nickel Hydrogenation;
With sodium sulfide; water
With 10% palladium on carbon; hydrogen In methanol; N,N-dimethyl-formamide
8-nitroquinazoline-4(3H)-one
53638-54-3

8-nitroquinazoline-4(3H)-one

4-chloro-8-nitroquinazoline
19815-18-0

4-chloro-8-nitroquinazoline

Conditions
ConditionsYield
Stage #1: 8-nitroquinazoline-4(3H)-one With trichlorophosphate In N,N-dimethyl-aniline at 0 - 65℃; for 1.5h;
Stage #2: With sodium hydrogencarbonate
59.63%
With phosphorus pentachloride; trichlorophosphate
With phosphorus pentachloride; trichlorophosphate for 4h; Reagent/catalyst; Reflux;1 g
Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: POCl3; PCl5
2: methanol
3: palladium/CaCO3; methanol / Hydrogenation
View Scheme

53638-54-3Relevant articles and documents

A in the aqueous phase under microwave conditions using halogenated benzamide fast synthesis of quinazoline compounds of the method

-

Paragraph 0015; 0046, (2019/02/13)

The invention discloses a in the aqueous phase under microwave conditions using halogenated benzamide fast synthesis of quinazoline compounds of the method, the use of palladium chloride to serve as the catalyst, in water under microwave heating conditions, neighbouring halogen benzamide with an isocyanate reaction to produce the quinazoline compounds of the method, the invention an environment-friendly, the operation is simple, cheap and safe, efficient process for producing quinazoline compounds of the method. Compared with the prior art, this method not only can be applied to a large number of functional groups, the productive rate is high, few by-products, and the operation is simple, safe, low cost, environmental protection.

BICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS

-

Paragraph 0308; 0309; 0310, (2013/08/28)

The present disclosure is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases.

Novel Sulfonaminoquinoline Hepcidin Antagonists

-

Page/Page column 173, (2012/09/05)

The present invention relates to novel hepcidin antagonists, pharmaceutical compositions comprising them and the use thereof as medicaments for the use in the treatment of iron metabolism disorders, such as, in particular, iron deficiency diseases and anemias, in particular anemias in connection with chronic inflammatory diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 53638-54-3